BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34941028)

  • 1. Physical activity programmes for patients undergoing neo-adjuvant chemoradiotherapy for rectal cancer: A systematic review and meta-analysis.
    Latrille M; Buchs NC; Ris F; Koessler T
    Medicine (Baltimore); 2021 Dec; 100(51):e27754. PubMed ID: 34941028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and preliminary effectiveness of a physical exercise training program during neoadjuvant chemoradiotherapy in individual patients with rectal cancer prior to major elective surgery.
    Heldens AF; Bongers BC; de Vos-Geelen J; van Meeteren NL; Lenssen AF
    Eur J Surg Oncol; 2016 Sep; 42(9):1322-30. PubMed ID: 27156145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Phase I Study Examining the Feasibility and Safety of an Aerobic Exercise Intervention in Patients With Rectal Cancer During and After Neoadjuvant Chemoradiotherapy.
    Morielli AR; Usmani N; Boulé NG; Tankel K; Severin D; Nijjar T; Joseph K; Courneya KS
    Oncol Nurs Forum; 2016 May; 43(3):352-62. PubMed ID: 27105196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prehabilitation is feasible in patients with rectal cancer undergoing neoadjuvant chemoradiotherapy and may minimize physical deterioration: results from the REx trial.
    Moug SJ; Mutrie N; Barry SJE; Mackay G; Steele RJC; Boachie C; Buchan C; Anderson AS
    Colorectal Dis; 2019 May; 21(5):548-562. PubMed ID: 30657249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of prehabilitation on objectively measured physical fitness after neoadjuvant treatment in preoperative rectal cancer patients: a blinded interventional pilot study.
    West MA; Loughney L; Lythgoe D; Barben CP; Sripadam R; Kemp GJ; Grocott MP; Jack S
    Br J Anaesth; 2015 Feb; 114(2):244-51. PubMed ID: 25274049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise prehabilitation may lead to augmented tumor regression following neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    West MA; Astin R; Moyses HE; Cave J; White D; Levett DZH; Bates A; Brown G; Grocott MPW; Jack S
    Acta Oncol; 2019 May; 58(5):588-595. PubMed ID: 30724668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise during and after neoadjuvant rectal cancer treatment (the EXERT trial): study protocol for a randomized controlled trial.
    Morielli AR; Usmani N; Boulé NG; Severin D; Tankel K; Nijjar T; Joseph K; Fairchild A; Courneya KS
    Trials; 2018 Jan; 19(1):35. PubMed ID: 29329555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of neoadjuvant chemoradiotherapy on physical fitness and morbidity in rectal cancer surgery patients.
    West MA; Loughney L; Barben CP; Sripadam R; Kemp GJ; Grocott MP; Jack S
    Eur J Surg Oncol; 2014 Nov; 40(11):1421-8. PubMed ID: 24784775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise motivation in rectal cancer patients during and after neoadjuvant chemoradiotherapy.
    Morielli AR; Usmani N; Boulé NG; Severin D; Tankel K; Nijjar T; Joseph K; Courneya KS
    Support Care Cancer; 2016 Jul; 24(7):2919-26. PubMed ID: 26847350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effects of oxaliplatin-based neoadjuvant chemotherapy and chemoradiotherapy in patients with locally advanced rectal cancer: a single-center, retrospective cohort study.
    Okuyama T; Sameshima S; Takeshita E; Yoshioka R; Yamagata Y; Ono Y; Tagaya N; Noie T; Oya M
    World J Surg Oncol; 2018 Jun; 16(1):105. PubMed ID: 29871650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of efficacy and safety of preoperative Chemoradiotherapy in locally advanced upper and middle/lower rectal cancer.
    Huang MY; Lee HH; Tsai HL; Huang CW; Yeh YS; Ma CJ; Huang CM; Chen CY; Huang JJ; Wang JY
    Radiat Oncol; 2018 Mar; 13(1):53. PubMed ID: 29587797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing of surgery following neoadjuvant chemoradiotherapy in locally advanced rectal cancer - A comparison of magnetic resonance imaging at two time points and histopathological responses.
    West MA; Dimitrov BD; Moyses HE; Kemp GJ; Loughney L; White D; Grocott MP; Jack S; Brown G
    Eur J Surg Oncol; 2016 Sep; 42(9):1350-8. PubMed ID: 27160356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of adherence to aerobic exercise in rectal cancer patients during and after neoadjuvant chemoradiotherapy.
    Morielli AR; Boulé NG; Usmani N; Joseph K; Tankel K; Severin D; Courneya KS
    Psychol Health Med; 2018 Feb; 23(2):224-231. PubMed ID: 28635312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prehabilitation in rectal surgery: a narrative review.
    Hannan E; Kelly ME; Fahy MR; Winter DC
    Int J Colorectal Dis; 2022 Feb; 37(2):293-299. PubMed ID: 35006332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise prehabilitation program for patients under neoadjuvant treatment for rectal cancer: A pilot study.
    Alejo LB; Pagola-Aldazabal I; Fiuza-Luces C; Huerga D; de Torres MV; Verdugo AS; Ortega Solano MJ; Felipe JL; Lucia A; Ruiz-Casado A
    J Cancer Res Ther; 2019; 15(1):20-25. PubMed ID: 30880749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic impact of neoadjuvant chemoradiotherapy on lymph node sampling in patients with locally advanced rectal cancer.
    Li Destri G; Maugeri A; Ramistella A; La Greca G; Conti P; Trombatore G; Vecchio GM; Magro GG; Barchitta M; Agodi A
    Updates Surg; 2020 Sep; 72(3):793-800. PubMed ID: 32632764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of tumour regression grade after neoadjuvant chemoradiotherapy for a cohort of patients with locally advanced rectal cancer: an 8-year retrospective single-institutional study.
    Xu L; Cai S; Xiao T; Chen Y; Qiu H; Wu B; Lin G; Sun X; Lu J; Zhou W; Xiao Y
    Colorectal Dis; 2017 Jul; 19(7):O263-O271. PubMed ID: 28603932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does prehabilitation modify muscle mass in patients with rectal cancer undergoing neoadjuvant therapy? A subanalysis from the REx randomised controlled trial.
    Moug SJ; Barry SJE; Maguire S; Johns N; Dolan D; Steele RJC; Buchan C; Mackay G; Anderson AS; Mutrie N
    Tech Coloproctol; 2020 Sep; 24(9):959-964. PubMed ID: 32564236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of platelet-associated biomarkers in rectal cancer patients received neoadjuvant chemoradiation: A retrospective study.
    Wang P; Wang Z; Liu Y; Xie J; Ren Y
    Cancer Radiother; 2021 Apr; 25(2):147-154. PubMed ID: 33423969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    Lin H; Wang L; Zhong X; Zhang X; Shao L; Wu J
    World J Surg Oncol; 2021 May; 19(1):141. PubMed ID: 33952287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.